UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review

Addiction biology, 2013-01, Vol.18 (1), p.121-133

2013

Volltextzugriff (PDF)

Naltrexone for the Management of Alcohol Dependence

The New England journal of medicine, 2008-08, Vol.359 (7), p.715-721

Anton, Raymond F

2008

Volltextzugriff (PDF)

Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels

Alcoholism, clinical and experimental research, 2017-01, Vol.41 (1), p.179-186

2017

Volltextzugriff (PDF)

Left frontal pole theta burst stimulation decreases orbitofrontal and insula activity in cocaine users and alcohol users

Drug and alcohol dependence, 2017-09, Vol.178, p.310-317

2017

Volltextzugriff (PDF)

A Double-Blind Trial of Gabapentin Versus Lorazepam in the Treatment of Alcohol Withdrawal

Alcoholism, clinical and experimental research, 2009-09, Vol.33 (9), p.1582-1588

2009

Volltextzugriff (PDF)

Differential Brain Activity in Alcoholics and Social Drinkers to Alcohol Cues: Relationship to Craving

Neuropsychopharmacology (New York, N.Y.), 2004-02, Vol.29 (2), p.393-402

2004

Volltextzugriff (PDF)

Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial

JAMA internal medicine, 2020-05, Vol.180 (5), p.728

2020

Volltextzugriff (PDF)

Harmonization of measurement results of the alcohol biomarker carbohydrate-deficient transferrin by use of the toolbox of technical procedures of the International Consortium for Harmonization of Clinical Laboratory Results

Clinical chemistry (Baltimore, Md.), 2014-07, Vol.60 (7), p.945-953

2014

Volltextzugriff (PDF)

OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach

Alcoholism, clinical and experimental research, 2009-03, Vol.33 (3), p.383-393

2009

Volltextzugriff (PDF)

A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence

Journal of clinical psychopharmacology, 2008-02, Vol.28 (1), p.5-12

2008

Volltextzugriff (PDF)

The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics

Journal of clinical psychopharmacology, 2010-08, Vol.30 (4), p.365-372

2010

Volltextzugriff (PDF)

Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence

Journal of human genetics, 2012-10, Vol.57 (10), p.670-675

2012

Volltextzugriff (PDF)

Changed Primary Outcome Between Trial Registration and Publication—Reply

JAMA internal medicine, 2020-11, Vol.180 (11), p.1551

2020

Volltextzugriff (PDF)

The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice

Alcoholism, clinical and experimental research, 2016-11, Vol.40 (11), p.2292-2295

2016

Volltextzugriff (PDF)

Effects of Naltrexone and Nalmefene on Subjective Response to Alcohol Among Non-Treatment-Seeking Alcoholics and Social Drinkers

Alcoholism, clinical and experimental research, 2004-09, Vol.28 (9), p.1362-1370

2004

Volltextzugriff (PDF)

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status

Neuropsychopharmacology (New York, N.Y.), 2017-12, Vol.42 (13), p.2640-2653

2017

Volltextzugriff (PDF)

Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder

Alcoholism, clinical and experimental research, 2018-12, Vol.42 (12), p.2453-2465

2018

Volltextzugriff (PDF)

Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial

The American journal of psychiatry, 2021-09, Vol.178 (9), p.829-837

2021

Volltextzugriff (PDF)

The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001–2002 and 2012–2013

The American journal of psychiatry, 2021-06, Vol.178 (6), p.548-559

2021

Volltextzugriff (PDF)

Validation of Blood Phosphatidylethanol as an Alcohol Consumption Biomarker in Patients with Chronic Liver Disease

Alcoholism, clinical and experimental research, 2014-06, Vol.38 (6), p.1706-1711

2014

Volltextzugriff (PDF)

Assessment and treatment of mood disorders in the context of substance abuse

Dialogues in clinical neuroscience, 2015-06, Vol.17 (2), p.181-190

2015

Volltextzugriff (PDF)

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials

JAMA psychiatry (Chicago, Ill.), 2019-04, Vol.76 (4), p.374

2019

Volltextzugriff (PDF)

Interaction of FKBP5 with Childhood Adversity on Risk for Post-Traumatic Stress Disorder

Neuropsychopharmacology (New York, N.Y.), 2010-07, Vol.35 (8), p.1684-1692

2010

Volltextzugriff (PDF)

World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom

Addiction (Abingdon, England), 2020-09, Vol.115 (9), p.1668-1680

2020

Volltextzugriff (PDF)

A Phase 2, Placebo-Controlled Study of the Opioid Receptor Antagonist LY2196044 for the Treatment of Alcohol Dependence

Alcoholism, clinical and experimental research, 2014-02, Vol.38 (2), p.511-520

2014

Volltextzugriff (PDF)

1 – 25 von 354

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(317)
Mit Volltextzugriff
(278)

Publikationsform

Sprache

Englisch
(353)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Life Sciences & Biomedicine
(239)
Humans
(213)
Female
(148)
Male
(148)
Adult
(135)
Biological And Medical Sciences
(126)
Medical Sciences
(120)
Substance Abuse
(118)
Middle Aged
(99)
Alcoholism
(90)
Toxicology
(78)
Psychiatry
(77)
Alcoholism And Acute Alcohol Poisoning
(71)
Psychology. Psychoanalysis. Psychiatry
(68)
Psychopathology. Psychiatry
(61)
Alcoholism - Drug Therapy
(54)
Treatment Outcome
(52)
Adult And Adolescent Clinical Studies
(49)
Alcohol Use
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review

Naltrexone for the Management of Alcohol Dependence

Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels

Left frontal pole theta burst stimulation decreases orbitofrontal and insula activity in cocaine users and alcohol users

A Double-Blind Trial of Gabapentin Versus Lorazepam in the Treatment of Alcohol Withdrawal

Differential Brain Activity in Alcoholics and Social Drinkers to Alcohol Cues: Relationship to Craving

Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial

Harmonization of measurement results of the alcohol biomarker carbohydrate-deficient transferrin by use of the toolbox of technical procedures of the International Consortium for Harmonization of Clinical Laboratory Results

OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach

A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence

The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics

Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence

Changed Primary Outcome Between Trial Registration and Publication—Reply

The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice

Effects of Naltrexone and Nalmefene on Subjective Response to Alcohol Among Non-Treatment-Seeking Alcoholics and Social Drinkers

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status

Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder

Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial

The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001–2002 and 2012–2013

Validation of Blood Phosphatidylethanol as an Alcohol Consumption Biomarker in Patients with Chronic Liver Disease

Assessment and treatment of mood disorders in the context of substance abuse

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials

Interaction of FKBP5 with Childhood Adversity on Risk for Post-Traumatic Stress Disorder

World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom

A Phase 2, Placebo-Controlled Study of the Opioid Receptor Antagonist LY2196044 for the Treatment of Alcohol Dependence

Suchergebnisse filtern